Cargando…
Pharmacokinetic Profile of Oral Administration of Mefloquine to Clinically Normal Cats: A Preliminary In-Vivo Study of a Potential Treatment for Feline Infectious Peritonitis (FIP)
SIMPLE SUMMARY: In searching for antiviral agents against feline coronaviruses and feline caliciviruses, mefloquine, a human anti-malarial drug, has been demonstrated to reduce viral load of feline coronaviruses and feline calicivirus in infected cells. In this study, mefloquine was administered ora...
Autores principales: | Yu, Jane, Kimble, Benjamin, Norris, Jacqueline M., Govendir, Merran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341284/ https://www.ncbi.nlm.nih.gov/pubmed/32521771 http://dx.doi.org/10.3390/ani10061000 |
Ejemplares similares
-
Assay validation and determination of in vitro binding of mefloquine to plasma proteins from clinically normal and FIP-affected cats
por: Izes, Aaron M., et al.
Publicado: (2020) -
In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula)
por: Izes, Aaron Michael, et al.
Publicado: (2020) -
Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats
por: Izes, Aaron M., et al.
Publicado: (2020) -
Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS‐441524
por: Coggins, Sally J., et al.
Publicado: (2023) -
Immunohistochemical studies on meningoencephalitis in feline infectious
peritonitis (FIP)
por: WANG, Huanan, et al.
Publicado: (2018)